Business Wire10h
Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...
Hosted on MSN15h
As Microsoft 365 Fees Increase, This Lifetime Version Remains the Cheapest Option
If you haven’t heard the news, Microsoft raised the price of its 365 subscription service for the first time in 12 years. It’s probably not that surprising if you have other subscription fees pulling ...
Hosted on MSN23h
The Microsoft Office Clipboard Can Do More Than You Think
Unlike the Windows 11 clipboard, the Microsoft Office clipboard stays on screen as you work. The Office clipboard can store ...
Your slides and presentations are about to get a whole lot more interesting with this Microsoft app
You might just impress clients and colleagues—and avoid yawning faces—with Microsoft Visio's diagramming features. It ...
rmdopen.bmj15d
Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells
Objectives Interleukin (IL)-17 signalling has been shown to be a key regulator of disease in ankylosing spondylitis (AS) with several IL-17 blockers currently clinically approved. Despite this, the ...
gut.bmj16d
Big data in IBD: big progress for clinical practice
Correspondence to Dr Séverine Vermeire, Department of Chronic Diseases, Metabolism and Ageing - TARGID, KU Leuven, Leuven B-3000, Belgium; severine.vermeire{at}uzleuven.be IBD is a complex ...
BMJ16d
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
Objectives The Assessment of SpondyloArthritis International Society (ASAS) aimed to develop a set of quality standards (QS) to help improve the quality of healthcare provided to adult patients ...
gut.bmj16d
Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies
Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, carrying a greater risk of developing cirrhosis and its complications. For decades, pegylated interferon alpha (PegIFN-α) has ...
rmdopen.bmj16d
Artificial intelligence in rheumatology research: what is it good for?
Artificial intelligence (AI) is transforming rheumatology research, with a myriad of studies aiming to improve diagnosis, prognosis and treatment prediction, while also showing potential capability to ...
thorax.bmj16d
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
Background Fibrotic interstitial lung diseases (fILDs) are a heterogeneous group of lung diseases associated with significant morbidity and mortality. Despite a large increase in the number of ...
C&EN16d
A Medicinal Chemistry Perspective on FDA-Approved Small Molecule Drugs with a Covalent Mechanism of Action
Department of Discovery Chemistry, MSD, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom ...
BMJ16d
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China
10 Department of Cardiology, The First Hospital of Jilin University, Changchun, China 11 Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of ...